Mon.Jul 03, 2023

article thumbnail

How to Build Your Career as a Medical Sales Person?

David Bagga

Building your career as a salesperson in the medical field requires great planning. Here are some tips to boost your efforts. When it comes to the medical sales career, Medical Device Sales Career Home Blog How to Build Your Career as a Medical… How to Build Your Career as a Medical Sales Person? Building your […] The post How to Build Your Career as a Medical Sales Person?

article thumbnail

AstraZeneca, Daiichi Cancer Drug’s Phase 3 Results Clouded by Toxicity Concerns

MedCity News

An AstraZeneca and Daiichi Sankyo cancer drug achieved one of the main goals of a Phase 3 study in non-small cell lung cancer. But patient deaths were also reported in the study, and the companies disclosed few details about them.

Patients 108
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

DigitalHealth.London’s Accelerator programme selects Aide

PharmaTimes

Project aims to boost the adoption of technology across London’s NHS and help patients manage conditions - News - PharmaTimes

article thumbnail

Eli Lilly’s retatrutide sets new record for weight loss in obesity space

Pharmaceutical Technology

Pipeline developments within the obesity space have recently garnered interest following recent results published on Eli Lilly’s retatrutide.

119
119
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Ukrainian Writer Victoria Amelina Dies After Russian Attack

Copyright Clearance Center

Ukrainian novelist Victoria Amelina has died from injuries sustained from a Russian missile attack on June 27. She was 37. Her most recent work involved documenting human rights abuses in Ukrainian territory occupied by Russia.

98
article thumbnail

Save Someone’s Life in 5 Minutes or Let Them Die in 30?

MedCity News

In Pickens County, Alabama, cardiac arrests are now treated differently. Instead of immediately transporting patients, local EMS now work cardiac arrests in the field for 30 minutes; if there’s no change, they call it a “death in the field” because they know they cannot get the patient to a hospital in time for life-saving care. Why? Hospital closures now mean there’s no hospital nearby.

More Trending

article thumbnail

Startups Should Stop Being Afraid of Innovating the Medicaid Space, Exec Says

MedCity News

At a recent conference, Yuvo Health CEO Cesar Herrera said he is proud to bring value-based care to Medicaid populations, but he wishes there was more innovation activity dedicated to these beneficiaries. In his view, the main obstacles preventing startups from entering this space are ignorance about how the Medicaid market works and the false belief that they can’t make money in it.

article thumbnail

Generative AI – beyond the hype

Pharmaceutical Technology

2023 started with a buzz around ChatGPT, and more generally around the immense potential that generative AI (GenAI) holds.

105
105
article thumbnail

Virgin Pulse Expands Partnership with Headspace

MedCity News

Through an expanded partnership, Virgin Pulse’s clients who use the Homebase for Health platform can now access Headspace’s full suite of services. This includes an on-demand employee assistance program, clinical support and self-guided tools.

85
article thumbnail

Chinese NMPA approves Innovent and IASO Bio’s myeloma therapy

Pharmaceutical Technology

China has granted approval for Innovent Biologics and IASO Bio Fucaso for treating relapsed or refractory multiple myeloma (RRMM) in adults.

97
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Iodine Software Expands Partnership With OpenAI, Adds GPT-4 to Its Products

MedCity News

Iodine Software recently announced that it is expanding its relationship with OpenAI. By doing so, Iodine will integrate the latest GPT-4 language model into its existing AI technologies and datasets, specifically its AwareCDI product suite.

85
article thumbnail

Madrigal seeks expedited approval for NASH treatment

Pharmaceutical Technology

Madrigal Pharmaceuticals has commenced a rolling submission of an NDA seeking expedited approval from the US FDA for resmetirom.

FDA 98
article thumbnail

6 Simple Steps to Create an Effective Sales Strategy

MedReps

It makes sense that in order to meet your sales goals, you first need to put together an effective sales strategy. Although everyone’s sales strategy might be a little different, each consists mainly of the same steps. If you’re ready to start making those sales, you’ll need to go through the six steps described here in order to develop your own plan.

article thumbnail

Camena bags $10m in funding from Mercia

Pharmaceutical Technology

The bioscience company has received $10m Series A financing from asset manager Mercia.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

MA Enrollees Less Likely To Be Prescribed High-risk Medications Than Traditional Medicare Enrollees

MedCity News

In 2018, there were 41.5 high-risk medications per 1,000 beneficiaries for Medicare Advantage, compared to 56.9 high-risk medications per 1,000 beneficiaries for traditional Medicare, a new study found.

Medical 62
article thumbnail

BMS’ Sotyktu gets NICE green light for NHS use

PharmaTimes

The therapy becomes an option for moderate-to-severe plaque psoriasis in certain adults - News - PharmaTimes

81
article thumbnail

Baudax Bio acquires biotechnology firm TeraImmune

Pharmaceutical Technology

Baudax Bio has acquired all outstanding equity interests of biotechnology firm TeraImmune in a stock-for-stock deal.

64
article thumbnail

The stories you’ve read the most in 2023 (so far)

PharmaVoice

From staff shortages to presidential candidates and the M&A outlook, here are our most-read stories from the first half of the year.

52
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Chime Biologics, Leads and Beigene enter antibody development deal

Pharmaceutical Technology

Chime Biologics, Leads Biolabs and BeiGene have entered a strategic partnership to expedite the development of a monoclonal antibody, LBL-007.

Leads 52
article thumbnail

Best of VOC: Beyond Publishers

Copyright Clearance Center

Publishing industry analyst Rüdiger Wischenbart wants your help to map the new uncharted territories of the book business.

52
article thumbnail

Zealand Pharma submits NDA for hyperinsulinism drug dasiglucagon

Pharmaceutical Technology

The NDA includes pivotal data from Phase III trials and a long-term extension, with one trial missing its primary endpoint.

Pharma 52
article thumbnail

Investigational Stem Cell-Derived Islet Cell Therapy Shows Promise in Treatment of Type 1 Diabetes

Pharmacy Times

All individuals with type 1 diabetes on the therapy had restored insulin secretion, improved glycemic control, improved time-in-range reduction, or elimination of exogenous insulin usage.

49
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Cyltezo Pen: first interchangeable biosimilar to Humira rolls out across US

Pharmaceutical Technology

The Humira biosimilar from Boehringer Ingelheim launches amidst a loss of exclusivity for AbbieVie’s blockbuster drug.

52
article thumbnail

Current HVBP Value Weights Do Not Reflect Preferences of Medicare Beneficiaries

Pharmacy Times

Using data from a wide-ranging survey of Medicare enrollees, investigators found that using value weights from participants would have a negative impact on smaller, rural hospitals.

49
article thumbnail

The VPAS fallout continues – Celltrion pulls high-profile biosimilar from UK market

Pharmaceutical Technology

In late June 2023, Celltrion (South Korea) withdrew its key anti-cancer biosimilar, Herzuma, from the UK market.

article thumbnail

Study Finds Comorbidities, Pre-Existing Disease Have Significant Impact On COVID-19 Outcomes

Pharmacy Times

The study also found significant evidence of outcomes disparities between minority populations and White populations.

59
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

8 Best Solar Sales Training Resources

Spotio

The solar industry is growing by leaps and bounds. You must train your sales reps to close deals consistently to help your company grab a piece of this lucrative pie. Fortunately, there are a bunch of resources to help you. So that’s what we’ll cover in this article. Keep reading about the eight best solar sales training online courses available in 2023.

article thumbnail

Overall Inequalities in Diabetes Incidence Improves for Race, Ethnicity in Recent Years, Though Still Persisting

Pharmacy Times

The prevalence of undiagnosed diabetes in earlier years in racial and ethnic minorities and lower education groups, leading to a decline in incidence over time.

article thumbnail

Monthly Employee Portal Updates | June 2023

Progressive Medical

You must be a registered user to view this information. The post Monthly Employee Portal Updates | June 2023 appeared first on Progressive Medical, Inc.

Medical 40
article thumbnail

American Diabetes Association, Abbott Announce Collaboration on Nutrition Program for Those with Diabetes

Pharmacy Times

The collaboration will focus on engaging with health experts and opinion leaders to examine data to gain a better understanding of the role continuous glucose monitoring systems have in personalized therapeutic nutrition.

29
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.